Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.05%
SPX
+1.03%
IXIC
+1.20%
FTSE
+0.30%
N225
+0.50%
AXJO
-0.27%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
3.59B
Dividend Yield
0.00%
P/E Ratio
-9.31
EPS
-4.35
Revenue
37.31M
Avg. Volume
1.65M

Recently from Cashu

publisher logo
Cashu

CRISPR Therapeutics AG: Market Growth Driven by Advances in Gene Editing and Precision Medicine

2 days ago
publisher logo
Cashu

CRISPR Therapeutics AG Poised for Growth in Expanding CRISPR Market by 2032

4 days ago
publisher logo
Cashu

CRISPR Therapeutics AG Positioned for Growth in Expanding Gene Editing Market

6 days ago

About

What does CRSP do?
CRISPR Therapeutics AG, headquartered in Zug, develops gene-based medicines for serious diseases using its CRISPR/Cas9 platform and went public on October 19, 2016. The company focuses on gene editing to treat genetically-defined diseases and enhance cellular therapies.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Switzerland
Website
http://www.crisprtx.com
Stocks
Health Care
crsp
CRISPR Therapeutics AG
CRSP
+3.35 (+8.70%)
41.925
USD
At close at Jun 06, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials